It remains the first and only FDA-approved obesity treatment that activates both GIP and GLP-1 receptors, making it potentially more potent than previous GLP-1 medications solely targeting GLP-1 for weight management
It is also the most insidious because you cannot detect it without sending a sample to a lab
Valid concerns include lack of oversight, variability between batches, no recourse if something goes wrong, and potential legal implications
it cannot be legally prescribed in the UK outside of authorised clinical trials
During this process, each amino acid residue is sequentially added to a growing chain attached to a solid support
Four states eliminated coverage in that window: California, New Hampshire, Pennsylvania, and South Carolina